S&P 및 Nasdaq 내재가치 문의하기

TFF Pharmaceuticals, Inc. TFFP NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
43/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 TFF Pharmaceuticals, Inc. (TFFP), 포함 42 건 매수4 건 매도. 내부자 매수 총액은 $823.75K 내부자 매도 총액은 $684.23K.

최근 활동이 있는 주요 내부자에는 Rocamboli Stephen, Mills Robert S, King Thomas Braxton. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — TFFP

날짜 이름 직책 거래 유형 주식수 평균 가격 금액 보유 주식수
2024-07-03 Rocamboli Stephen Director RSU 부여 3,165 $1.82 $5.76K 3,165
2024-07-03 Mills Robert S Director RSU 부여 3,165 $1.82 $5.76K 3,165
2024-07-03 King Thomas Braxton Director RSU 부여 1,583 $1.82 $2.88K 1,583
2024-07-03 Roberts Brandi Director RSU 부여 3,165 $1.82 $5.76K 3,165
2024-07-03 Lee Catherine Chai-zon Director RSU 부여 1,583 $1.82 $2.88K 1,583
2024-07-03 Weisman Harlan F President and CEO RSU 부여 27,480 $1.82 $50.01K 27,480
2024-07-03 Coleman Kirk Allen Chief Financial Officer RSU 부여 10,184 $1.82 $18.53K 10,184
2024-07-03 Mikhak Zamaneh Chief Medical Officer RSU 부여 10,184 $1.82 $18.53K 10,184
2024-04-18 Rocamboli Stephen Director RSU 부여 4,667 - - 4,667
2024-04-18 Mills Robert S Director RSU 부여 4,667 - - 4,667
2024-04-18 King Thomas Braxton Director RSU 부여 3,110 - - 3,110
2024-04-18 Roberts Brandi Director RSU 부여 5,333 - - 5,333
2024-04-18 Lee Catherine Chai-zon Director RSU 부여 3,556 - - 3,556
2024-04-18 Weisman Harlan F President and CEO RSU 부여 44,967 - - 44,967
2024-04-18 Coleman Kirk Allen Chief Financial Officer RSU 부여 5,300 - - 5,300
2024-04-18 Mikhak Zamaneh Chief Medical Officer RSU 부여 5,300 - - 5,300
2024-04-18 Patane Michael A Director RSU 부여 3,556 - - 3,556
2023-12-13 King Thomas Braxton Director RSU 부여 132,442 $0.35 $46.35K 132,442
2023-12-11 King Thomas Braxton Director 알 수 없음 - - - -
2023-12-01 Rocamboli Stephen Director RSU 부여 52,858 $0.36 $19.03K 52,858
2023-12-01 Mills Robert S Director RSU 부여 52,858 $0.36 $19.03K 52,858
2023-12-01 Roberts Brandi Director RSU 부여 52,858 $0.36 $19.03K 52,858
2023-12-01 Lee Catherine Chai-zon Director 알 수 없음 - - - -
2023-12-01 Lee Catherine Chai-zon Director RSU 부여 132,442 $0.36 $47.68K 132,442
2023-12-01 Patane Michael A Director 알 수 없음 - - - -
2023-12-01 Patane Michael A Director RSU 부여 132,442 $0.36 $47.68K 132,442
2023-08-16 Carlson Capital L P 10 Percent Owner 정보 매도 1,000 $0.39 $391.60 5,064,000
2023-08-15 Rocamboli Stephen Director 정보 매수 20,000 $0.25 $5K 36,000
2023-08-15 Mills Robert S Director 정보 매수 40,000 $0.25 $10K 55,980
2023-08-15 Roberts Brandi Director 정보 매수 20,000 $0.25 $5K 20,000
2023-08-15 Weisman Harlan F President and CEO 정보 매수 600,000 $0.25 $150K 814,615
2023-08-15 Coleman Kirk Allen Chief Financial Officer 정보 매수 20,000 $0.25 $5K 35,675
2023-08-15 Mikhak Zamaneh Chief Medical Officer 정보 매수 120,000 $0.25 $30K 135,000
2023-08-15 Carlson Capital L P 10 Percent Owner 알 수 없음 600,000 $1.29 $774K -
2023-08-15 Carlson Capital L P 10 Percent Owner 정보 매도 215,000 $0.44 $94.04K 5,065,000
2023-03-22 Coleman Kirk Allen Chief Financial Officer RSU 부여 100,000 $0.80 $80K 100,000
2023-03-10 Rocamboli Stephen Director 정보 매수 13,000 $0.80 $10.43K 16,000
2023-03-10 Weisman Harlan F President and CEO 정보 매수 150,000 $0.88 $131.84K 214,615
2023-03-10 Coleman Kirk Allen Chief Financial Officer 정보 매수 12,000 $0.79 $9.46K 15,675
2023-03-10 Mikhak Zamaneh Chief Medical Officer 정보 매수 15,000 $0.82 $12.3K 15,000
2023-01-05 Mikhak Zamaneh Chief Medical Officer 처분 430,000 $0.97 $417.1K -
2022-12-29 Rocamboli Stephen Director RSU 부여 33,475 - - 33,475
2022-12-29 Mills Robert S Director RSU 부여 33,475 - - 33,475
2022-12-29 Roberts Brandi Director RSU 부여 20,968 - - 20,968
2022-12-29 Fletcher Aaron G.l. Director RSU 부여 33,475 - - 33,475
2022-12-15 Weisman Harlan F President and CEO 정보 매수 50,000 $1.06 $53K 64,615
2022-12-03 Weisman Harlan F President and CEO RSU 부여 1,792,450 - - 1,792,450
2022-11-22 Fletcher Aaron G.l. Director 정보 매수 21,735 - - 21,735
2022-09-29 Thurman Randy H Director 정보 매도 40,255 $4.29 $172.69K -
2022-05-18 Weisman Harlan F Director 정보 매수 2,500 $5.12 $12.8K 10,000
정보 기반 — 공개 시장 거래 (가장 중요) 비정보 매수 — 보상, 옵션 행사, 전환 비정보 매도 — 세금 원천징수, 부여 매도 중립 — 증여, 신탁, 만료
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기